9 results
Treatment Algorithm for First Time Pulmonary Embolism
 • Provoked
 • Unprovoked
 • Active Malignancy

By Carlin Rooke,
Treatment Algorithm ... #PE #Pulmonary # ... #Algorithm #management ... #hematology #VTE ... #thrombosis #venous
Lower Extremity Venous Thrombosis - Management and Anatomy

Deep - Superficial - Active Bleeding

#LowerExtremity #Veins #Venous #Thrombosis
- Management and ... Superficial #Deep #VTE ... #DVT #Hematology ... #Management #Anatomy ... Anticoagulation #Algorithm
Upper Extremity Venous Thrombosis - Management and Anatomy

Deep - Superficial - Catheter Associated

#UpperExtremity #Veins #Venous #Thrombosis
- Management and ... Superficial #Deep #VTE ... #DVT #Hematology ... #Management #Anatomy ... Anticoagulation #Algorithm
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
stratification algorithm ... for the treatment ... ; PE = pulmonary ... Anticoagulation #Management ... #Hematology #Oncology
Treatment algorithm for VTE in Malignancy

(A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
Treatment algorithm ... incidental DVT or PE ... thrombosis in cancer ... Anticoagulation #Management ... #Hematology #Oncology
Treatment Algorithm for First Time DVT
 • Provoked
 • Unprovoked
 • Active Malignancy

By Carlin Rooke, MD.

#DVT
Treatment Algorithm ... #DVT #Treatment ... #Algorithm #management ... #hematology #VTE ... #thrombosis #venous
Clotmaster Consensus 2019: Duration of Therapy for Venous Thromboembolic Disease
 • Superficial Venous Thrombosis
 • Upper
/Muscular Vein Thrombosis ... DeLoughery @Bloodman #VTE ... anticoagulation #duration #management ... #DVT #hematology ... #length #treatment
Longterm Venous Thromboembolism Treatment Algorithm
Treat for 3 months and reassess
 • Isolated distal DVT (without cancer)
Algorithm Treat ... proximal DVT or PE ... therapy - Second VTE ... #Algorithm #management ... #hematology #anticoagulation
Essential Thrombocythemia (ET)
ET is a chronic myeloproliferative neoplasm. Most cases are related to mutations that affect
MI, stroke, DVT/PE ... • Treatment algorithms ... Thrombocythemia #ET #hematology ... #diagnosis #management ... #hematology